Bilgilendirme: Kurulum ve veri kapsamındaki çalışmalar devam etmektedir. Göstereceğiniz anlayış için teşekkür ederiz.
 

miR145 Suppresses Cell Proliferation by Targeting IGF1R and NRAS Genes in Multiple Myeloma Cells

dc.contributor.author Kaya, Murat
dc.contributor.author Suer, Ilknur
dc.contributor.author Ozgur, Emre
dc.contributor.author Capik, Ozel
dc.contributor.author Karatas, Omer Faruk
dc.contributor.author Ozturk, Sukru
dc.contributor.author Cefle, Kivanc
dc.date.accessioned 2026-03-26T14:58:54Z
dc.date.available 2026-03-26T14:58:54Z
dc.date.issued 2023
dc.description Gezer, Ugur/0000-0001-8471-5254; Palanduz, Sukru/0000-0002-9435-009X; Öztürk, Şükrü/0000-0002-8809-7462; Suer, İlknur/0000-0003-1954-4190; Çefle, Kivanç/0000-0002-9420-4543; Kaya, Murat/0000-0003-2241-7088; en_US
dc.description.abstract Objectives: Multiple myeloma (MM) is a common hematological cancer. Hence, it is important to conduct further studies investigating the molecular mechanisms in detail that contributes to myeloma genesis. In addition to genetic changes, epigenetic factors such as miRNAs may influence the expression of myeloma-related genes.Methods: Our study aimed to detect genes closely related to MM and miRNAs involved in the cancer process by changing the expression of these genes with bioinformatics tools and in vitro methods. Bioinformatics approaches identified hub miRNAs in our study that may have a role in the expression change of genes connected to myeloma. The functional impacts of the chosen miRNA on RPMI8226 and U266 cell lines and the effect of this miRNA on the expression changes of putative target genes were investigated.Results: The viability of miR-145-5p transfected cells was found to decrease compared to control cells and the expression of IGF1R and NRAS genes were found to be significantly suppressed in both cell lines at mRNA level. Decreased levels of the IGF1R and NRAS genes were confirmed in miR-145-5p transfected cells at the protein level as well as compared to control cells. In addition, IGF1R/miR-145-5p interaction was demonstrated via luciferase reporter assay. However, expression levels of EGFR, KLF4, IRS1, CDK4 and CDK6 candidate genes had no statistically significant difference in miR-145-5p transfected cells compared to control cells.Conclusions: Mir-145-5p was demonstrated to act as a tumor suppressor miRNA and inhibit the proliferation in MM cell lines via targeting IGF1R and NRAS. en_US
dc.description.sponsorship Istanbul University Scientific Research Projects Coordination Unit [31542] en_US
dc.description.sponsorship his work was supported by Istanbul University Scientific Research Projects Coordination Unit (Grant number 31542). en_US
dc.identifier.doi 10.1515/tjb-2023-0042
dc.identifier.issn 0250-4685
dc.identifier.issn 1303-829X
dc.identifier.scopus 2-s2.0-85176319125
dc.identifier.uri https://doi.org/10.1515/tjb-2023-0042
dc.identifier.uri https://search.trdizin.gov.tr/en/yayin/detay/1252436/mir-145-5p-suppresses-cell-proliferation-by-targeting-igf1r-and-nras-genes-in-multiple-myeloma-cells
dc.identifier.uri https://hdl.handle.net/20.500.14901/3208
dc.language.iso en en_US
dc.publisher Walter de Gruyter GmbH en_US
dc.relation.ispartof Turkish Journal of Biochemistry-Turk Biyokimya Dergisi en_US
dc.rights info:eu-repo/semantics/openAccess en_US
dc.subject Igf1R en_US
dc.subject Mir-145-5P en_US
dc.subject Multiple Myeloma en_US
dc.subject Nras en_US
dc.subject Rpmi-8226 en_US
dc.subject U266 en_US
dc.title miR145 Suppresses Cell Proliferation by Targeting IGF1R and NRAS Genes in Multiple Myeloma Cells en_US
dc.type Article en_US
dspace.entity.type Publication
gdc.author.id Gezer, Ugur/0000-0001-8471-5254
gdc.author.id Palanduz, Sukru/0000-0002-9435-009X
gdc.author.id Öztürk, Şükrü/0000-0002-8809-7462
gdc.author.id Suer, İlknur/0000-0003-1954-4190
gdc.author.id Çefle, Kivanç/0000-0002-9420-4543
gdc.author.id Kaya, Murat/0000-0003-2241-7088
gdc.author.scopusid 56233559400
gdc.author.scopusid 57198376647
gdc.author.scopusid 7004555357
gdc.author.scopusid 35598031000
gdc.author.scopusid 6603629212
gdc.author.scopusid 55068291500
gdc.author.scopusid 57202830045
gdc.author.wosid Gezer, Ugur/F-7853-2014
gdc.author.wosid Öztürk, Şükrü/Aac-5001-2020
gdc.author.wosid Ozgur, Emre/D-2102-2018
gdc.author.wosid Suer, İlknur/Aay-8643-2020
gdc.author.wosid Kaya, Murat/Afx-7428-2022
gdc.author.wosid Karatas, Omer/I-5103-2013
gdc.description.department Erzurum Technical University en_US
gdc.description.departmenttemp [Kaya, Murat; Suer, Ilknur; Ozturk, Sukru; Palanduz, Sukru; Cefle, Kivanc] Istanbul Univ, Istanbul Fac Med, Dept Internal Med, Div Med Genet, Istanbul, Turkiye; [Suer, Ilknur] Istanbul Univ, Istanbul Fac Med, Dept Med Genet, Istanbul, Turkiye; [Ozgur, Emre; Gezer, Ugur] Istanbul Univ, Oncol Inst, Dept Basic Oncol Diagnost Treatment & Care Serv, Istanbul, Turkiye; [Capik, Ozel; Karatas, Omer Faruk] Erzurum Tech Univ, Dept Mol Biol & Genet, Erzurum, Turkiye; [Capik, Ozel; Karatas, Omer Faruk] Erzurum Tech Univ, High Technol Applicat & Res Ctr, Mol Canc Biol Lab, Erzurum, Turkiye en_US
gdc.description.endpage 569 en_US
gdc.description.issue 5 en_US
gdc.description.publicationcategory Makale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı en_US
gdc.description.scopusquality Q4
gdc.description.startpage 563 en_US
gdc.description.volume 48 en_US
gdc.description.woscitationindex Science Citation Index Expanded
gdc.description.wosquality Q4
gdc.identifier.trdizinid 1252436
gdc.identifier.wos WOS:001021196300001
gdc.index.type Scopus

Files